T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Cullen/Frost Bankers
CFR
$10.4B
| $6.25M | ﹤0.01% |
49,254
+3,076
| +7% | +$400K |
|
1327
CareTrust REIT
CTRE
$9.18B
| $6.2M | ﹤0.01% |
178,686
+25,670
| +17% | +$844K |
|
1328
Immatics
IMTX
$1.33B
| $6.18M | ﹤0.01% |
+724,807
| New | +$4.46M |
|
1329
Idacorp
IDA
$8.21B
| $6.17M | ﹤0.01% |
46,693
+3,200
| +7% | +$396K |
|
1330
Jazz Pharmaceuticals
JAZZ
$16B
| $6.16M | ﹤0.01% |
46,704
+2,640
| +6% | +$317K |
|
1331
Oshkosh
OSK
$9.61B
| $6.12M | ﹤0.01% |
47,150
+3,504
| +8% | +$465K |
|
1332
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| $6.09M | ﹤0.01% |
113,970
| – | – |
|
1333
Qorvo
QRVO
$8.67B
| $6.07M | ﹤0.01% |
66,611
+1,458
| +2% | +$130K |
|
1334
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $6.05M | ﹤0.01% |
64,470
+3,747
| +6% | +$374K |
|
1335
Commercial Metals
CMC
$7.98B
| $6.04M | ﹤0.01% |
105,385
+5,598
| +6% | +$309K |
|
1336
Glacier Bancorp
GBCI
$6.48B
| $5.99M | ﹤0.01% |
122,977
+8,129
| +7% | +$381K |
|
1337
GFL Environmental
GFL
$14.7B
| $5.97M | ﹤0.01% |
125,973
+6,234
| +5% | +$302K |
|
1338
Kemper
KMPR
$1.56B
| $5.96M | ﹤0.01% |
115,592
+2,282
| +2% | +$128K |
|
1339
Relay Therapeutics
RLAY
$4.37B
| $5.94M | ﹤0.01% |
1,137,681
-1,738,255
| -60% | -$6.63M |
|
1340
MoonLake Immunotherapeutics
MLTX
$1.47B
| $5.9M | ﹤0.01% |
822,957
-1,790,276
| -69% | -$93.3M |
|
1341
GATX Corp
GATX
$6.34B
| $5.89M | ﹤0.01% |
33,694
+1,694
| +5% | +$274K |
|
1342
Lumen
LUMN
$6.6B
| $5.88M | ﹤0.01% |
960,564
+56,365
| +6% | +$271K |
|
1343
Advanced Energy
AEIS
$13.5B
| $5.87M | ﹤0.01% |
34,504
+1,778
| +5% | +$268K |
|
1344
Sanmina
SANM
$11.2B
| $5.85M | ﹤0.01% |
50,842
+2,486
| +5% | +$280K |
|
1345
James River Group Holdings
JRVR
$199M
| $5.81M | ﹤0.01% |
1,046,364
+87,145
| +9% | +$489K |
|
1346
Flowserve
FLS
$10.3B
| $5.79M | ﹤0.01% |
108,874
+6,028
| +6% | +$327K |
|
1347
Ryder
R
$10.1B
| $5.75M | ﹤0.01% |
30,484
+1,871
| +7% | +$337K |
|
1348
Varonis Systems
VRNS
$4.82B
| $5.74M | ﹤0.01% |
99,893
+7,107
| +8% | +$394K |
|
1349
Kyndryl
KD
$2.85B
| $5.74M | ﹤0.01% |
190,957
+12,042
| +7% | +$414K |
|
1350
American Airlines Group
AAL
$9.97B
| $5.73M | ﹤0.01% |
509,882
+41,423
| +9% | +$510K |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.